Shares of Super Micro Computer jumped after the company set a sales outlook for fiscal 2026 that blows past current Wall Street forecasts, unwinding a selloff earlier in the day.

This includes Pfizer’s purchase of ReViral for an estimated £420 million, Gilead ... central importance of R&D tax credits in leveraging the private investment that drives the UK life sciences ...

Biopharmaceutical company Gilead Sciences (NASDAQ:GILD) will be announcing earnings results tomorrow afternoon. Here’s what to expect. Gilead Sciences beat analysts’ revenue expectations by 7. ...

Andrew Dickinson, the Chief Financial Officer of Gilead Sciences, Inc. (NASDAQ:GILD), recently executed a series of transactions involving the company's stock. On February 12, Dickinson sold 137,676 ...

What Happened? Shares of biopharmaceutical company Gilead Sciences (NASDAQ:GILD) jumped 8.6% in the morning session after the ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Gilead Sciences has shored up its antibody-drug conjugate pipeline by licensing a candidate from German biotech Tubulis in a deal worth up to $415 million. The agreement includes an upfront ...

After hours: 7:56:43 pm GMT-5 ...